Drug profile · INN
iohexol
OMNIPAQUE 140
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
iohexol (OMNIPAQUE 140) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN iohexol
Brand OMNIPAQUE 140
Route ORAL
Formulation INJECTABLE
Originator Amneal Pharma Europe Ltd
Frequently asked questions
What is iohexol?
iohexol (OMNIPAQUE 140) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for iohexol?
OMNIPAQUE 140 is a marketed brand name for iohexol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of iohexol?
iohexol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.